Parexel acquires life sciences consulting firm Health Advances

By Melissa Fassbender

- Last updated on GMT

Image: iStock
Image: iStock
Parexel has acquired a life sciences strategy consulting firm as it continues to build on its existing portfolio.

The company announced the agreement to acquire all outstanding equity securities of Health Advances, an independent life sciences strategy consulting firm, yesterday.

At Parexel, we look for M&A opportunities that can complement or enhance our existing portfolio of capabilities​,” Goldberg told Outsourcing-Pharma.com.

"One area of interest has been consulting given the opportunity to build upon our heritage, leadership, and strength in this area​."

Health Advances currently employs approximately 120 scientists, clinicians, and business professionals across offices in the US and Europe, and works with more than half of the top 25 biopharmaceutical companies, as well as diagnostics and health information technology companies.

The combination affords us access to more clients in the medical device, diagnostics, and healthcare IT segments​,” said Goldberg.

Health Advances also offers portfolio planning, product positioning, markets assessment, and forecasting services.

With Health Advances, Parexel ​can offer an integrated development, market access, and commercialization solution at both the portfolio- and product-level,” ​explained Goldberg.

“Clients will be able to fulfill all of their development and commercialization needs – from strategic direction and guidance through execution – with a single company.​”

According to Parexel​, the acquisition is expected to close in February.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars